Value of scoring system in classification of proliferative breast disease on fine needle aspiration cytology

Rajan Shah, Arvind Kumar Sinha, Anju Pradhan, Rajat Kumar Agarwal

Abstract


Background: Fine needle aspiration cytology (FNAC) breast is generally considered as a rapid, safe and reliable diagnostic tool to distinguish benign from malignant breast lesions. Masood's Scoring Index has been proposed to categorize the breast lesions so as to help in surgical management. 

 Objectives: To find out the usefulness of Modified Masood’s scoring Index (MMSI) in proliferative breast diseases.

Materials and Methods: This is a prospective study, done over period of one year 2012 to 2013, which includes fifty cases of palpable breast lesions with cytological diagnosis, followed by histological confirmation on biopsy. MMSI was applied on corresponding FNAC aspirates. Breast lesions were categorized into four groups, non proliferative breast disease, proliferative breast disease (PBD) without atypia, PBD with atypia and carcinoma breast.

Results: Out of total 50 cases, age group ranged from 17-64 years.  Modification of Masood’s scoring system by shifting of score 9 and 10 from category I to category II, was found to be easily reproducible scoring method of breast lesions as it has improved the diagnostic accuracy of PBD.

Conclusion:  FNAC of breast is highly sensitive and specific modality for distinguishing benign and malignant lesions but its role in diagnosing proliferative breast lesions is debatable. MMSI can be applied on FNAC aspirates in stepwise manner after cytomorphological assessment to improve diagnostic accuracy of PBD without atypia.


Keywords


Modified Masood’s scoring, Proliferative breast disease, FNAC.

Full Text:

PDF

References


. Cochrane RA, Singhal H, Monypenny IJ, Webster DJ, Lyons K, Mansel RE. Evaluation of general practitioner referrals to a specialist breast clinic according to the UK national guidelines. European Journal of Surgical Oncology 1997; 23(3):198-201.

. Hughes JE, Royle GT, Buchanan R, Taylor I. Depression and social stress among patients with benign breast disease. The British Journal of Surgery. 1986; 73(12):997-9.

. Tiwari M. Role of fine needle aspiration cytology in diagnosis of breast lumps. Kathmandu University Medical Journal (KUMJ). 2007; 5(2): 215-7.

. Martin HE, Ellis EB. Biopsy by needle puncture and aspiration. Annals of Surgery. 1930; 92(2):169-81.

. Hindle WH, Payne PA, Pan EY. The use of fine-needle aspiration in the evaluation of persistent palpable dominant breast masses. American Journal of Obstetrics and Gynecology. 1993; 168(6 Pt 1):1814-8.

. Yong WS, Chia KH, Poh WT, Wong CY. A comparison of trucut biopsy with fine needle aspiration cytology in the diagnosis of breast cancer. Singapore Medical Journal. 1999; 40(9):587-9.

. Francis IM, Das DK. Role of fine needle aspiration, intraoperative imprint cytology and frozen section in the diagnosis of breast lumps and thyroid lesions. Medical Principles and Practice. 1999; 8:173-82.

. Dutta SK, Chattopadhyaya A, Roy S. Evaluation of fine needle aspiration and imprint cytology in the early diagnosis of breast lesions with histopathological correlation. Journal of the Indian Medical Association. 2001; 99(8):421-3.

. Lester SC. The Breast. In: Kumar V, Abbas AK, Fausto N, editor. Robbins & Cotran Pathologic basis of disease. 7th ed. Philadelphia, Pennsylvania. Elsevier; 2004. p. 1119-53.

. Carter D, Schnitt SJ, Millis RR. The Breast. In: Mills Stacey E. senior editor, Carter D et al editor. Sternberg's Diagnostic Surgical Pathology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2010.Vol 1. p. 330-50.

. Masood S. Cytomorphology of fibrocystic change, high-risk proliferative breast disease, and premalignant breast lesions. Clinics in Laboratory Medicine. 2005; 25(4):713-31.

. Fitzgibbons PL, Henson DE, Hutter RV. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Archives of Pathology & Laboratory Medicine. 1998; 122(12):1053-5.

. Page DL. Cancer risk assessment in benign breast biopsies. Human Pathology. 1986; 17(9):871-4.

. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. The New England Journal of Medicine. 1985; 312(3):146-51.

. Sidawy MK, Stoler MH, Frable WJ, Frost AR, Masood S, Miller TR, et al. Interobserver variability in the classification of proliferative breast lesions by fine-needle aspiration: results of the Papanicolaou Society of Cytopathology Study. Diagnostic Cytopathology. 1998; 18(2):150-65.

. Mridha AR, Iyer VK, Kapila K, Verma K. Value of scoring system in classification of proliferative breast disease on fine needle aspiration cytology. Indian Journal of Pathology & Microbiology. 2006; 49(3):334-40.

. Masood S, Frykberg ER, McLellan GL, Dee S, Bullard JB. Cytologic differentiation between proliferative and nonproliferative breast disease in mammographically guided fine-needle aspirates. Diagnostic Cytopathology. 1991; 7(6):581-90.

. Sneige N, Staerkel GA. Fine-needle aspiration cytology of ductal hyperplasia with and without atypia and ductal carcinoma in situ. Human Pathology. 1994; 25(5):485-92.

. Frost AR, Tabbara SO, Poprocky LA, Weiss H, Sidawy MK. Cytologic features of proliferative breast disease: a study designed to minimize sampling error. Cancer. 2000; 90(1):33-40.

. Thomas JS, Mallon EA, George WD. Semiquantitative analyses of fine needle aspirates from benign and malignant breast lesions. Journal of Clinical Pathology. 1989; 42(1):28-34.

. Nandini NM, Rekha TS, Manjunath GV. Evaluation of scoring system in cytological diagnosis and management of breast lesion with review of literature. Indian Journal of Cancer. 2011; 48(2):240-5.

. Kim A L, Kim H S, Kim H K, Won N H, Park M J, Koo B H. Fine needle aspiration cytology of breast lesions. Application of Masood’s Scoring System. Korean J Cytopathol 1998; 9(1):45-54.

. Frost AR, Aksu A, Kurstin R, Sidawy MK. Can nonproliferative breast disease and proliferative breast disease without atypia be distinguished by fine-needle aspiration cytology? Cancer. 1997; 81(1):22-8.

. Zajdela A, De LaRiva LS, Ghossein NA. The relation of prognosis to the nuclear diameter of breast cancer cells obtained by cytologic aspiration. Acta Cytologica. 1979; 23(1):75-80.

. Layfield LJ, Robert ME, Cramer H, Giuliano A. Aspiration biopsy smear pattern as a predictor of biologic behavior in adenocarcinoma of the breast. Acta Cytologica. 1992; 36(2):208-14.

. Black MM, Speer FD. Nuclear structure in cancer tissues. Surgery, Gynecology & Obstetrics. 1957; 105(1):97-102.

. Robinson IA, McKee G, Nicholson A, D'Arcy J, Jackson PA, Cook MG, et al. Prognostic value of cytological grading of fine-needle aspirates from breast carcinomas. Lancet. 1994; 343(8903):947-9.




DOI: http://dx.doi.org/10.7439/ijbr.v8i9.4371

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM

Refbacks

  • There are currently no refbacks.




Copyright (c) 2017 International Journal of Biomedical Research

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.